Home › Funds › SCHARF INVESTMENTS, LLC › CVS

SCHARF INVESTMENTS, LLC position in CVS

CVS HEALTH CORP · Consumer Staples

SCHARF INVESTMENTS, LLC reported holding 93,264 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$8.0M, representing 0.27% of its reported portfolio and ranking #35 among its reported holdings. SCHARF INVESTMENTS, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)93.26K sh
Reported value held$7.99M
Portfolio Weight0.27%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SCHARF INVESTMENTS, LLC's CVS position evolved

SCHARF INVESTMENTS, LLC first disclosed a stake in CVS in Q3 2023 at 2,211,506 shares (US$154.4M). The position peaked in Q4 2023 at 2,189,552 shares, worth US$172.9M. Across 13 filings, SCHARF INVESTMENTS, LLC increased the stake 1 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 93,264 shares valued at US$8.0M — a reduction of -603 shares quarter over quarter.. Notable position changes include a 46% trim in Q4 2024 (shares rose 53% over the following quarter), a 84% trim in Q1 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.21M $154.41M New
Q4 2023 2.19M $172.89M Reduce
Q1 2024 2.11M $168.66M Reduce
Q2 2024 1.98M $117.15M Reduce
Q3 2024 1.91M $119.80M Reduce
Q4 2024 1.02M $59.64M Reduce
Q1 2025 159.81K $10.83M Reduce
Q2 2025 125.89K $8.68M Reduce
Q3 2025 101.39K $7.64M Reduce
Q4 2025 103.50K $8.21M Add
Q1 2026 96.17K $6.91M Reduce
Q2 2026 93.87K $9.71M Reduce
Q3 2026 93.26K $7.99M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has SCHARF INVESTMENTS, LLC held CVS?

SCHARF INVESTMENTS, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SCHARF INVESTMENTS, LLC's current position in CVS?

As of Q3 2026, SCHARF INVESTMENTS, LLC holds 93.26K shares of CVS (CVS HEALTH CORP), valued at $7.99M, representing 0.27% of its reported portfolio and ranking #35.

Has SCHARF INVESTMENTS, LLC been buying or selling CVS?

In the latest 13F filing (Q3 2026), SCHARF INVESTMENTS, LLC reduced its position in CVS. The position peaked in Q4 2023 at 2.19M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.